We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Blood Management Program Reduces Unnecessary Transfusions

By HospiMedica International staff writers
Posted on 26 Sep 2017
Implementing a system-wide patient blood management program (BMP) can substantially reduce blood utilization and blood acquisition costs, claims a new study.

The blood management clinical community, formed at Johns Hopkins University School of Medicine (JHU-SOM; Baltimore, MD, USA), is a physician-led, multidisciplinary, collaborative, quality-improvement team formed in order to implement best practices for patient blood management. More...
To determine the effectiveness of the system, changes in blood utilization and blood acquisition costs were compared for the pre- and post-patient BMP implementation time periods.

The results revealed that across the health system, multiunit erythrocyte transfusion orders decreased from 39.7% to 20.2%, almost half. The percentage of patients transfused decreased for erythrocytes from 11.3% to 10.4%, for plasma from 2.9% to 2.2%, and for platelets from 3.1% to 2.7%. The number of units transfused per 1,000 patients also decreased; for erythrocytes by 19.8%; for plasma by 38.9%; and for platelets by 15.6%. Overall blood acquisition cost savings were USD 2,120,273 per year, an estimated 400% return on investment. The study was published on September 7, 2017, in Anesthesiology.

“Hospitals across the country are merging into health systems, in part to realize economies of scale by improving quality. Our experience with a patient blood management program shows that it's feasible to do that,” said lead author professor of anesthesiology and critical care medicine Steven Frank, MD. “Our premise is that doctors don't want to be told how to practice medicine by computer pop-up alerts; they would rather hear about the studies supporting the guidelines.”

The PBM program was launched in January 2012 at the Johns Hopkins Hospital with a clinical education program that consisted of live, in-person grand rounds presentations to various clinical departments in order to inform physicians, nurses, and other staff about hospital transfusion policy guidelines, and the results of eight published landmark studies that support reduced use of transfusions. The single most effective intervention, according to the study, was the “Why give 2 when 1 will do?" campaign to encourage single-unit transfusions.

Related Links:
Johns Hopkins University School of Medicine


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Radiofrequency Generator
GX1
New
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A high‑frequency ultrasound can inactivate enveloped respiratory viruses while sparing human cells (image credit: Adobe Stock)

High-Frequency Ultrasound Disables Viruses While Sparing Human Cells

Respiratory viral infections such as influenza A and COVID-19 continue to challenge patient management. Antiviral drugs are generally difficult to develop, and safe, broadly applicable options remain limited.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.